Antibiotic stewardship in dermatology: Limiting antibiotic use in acne

European Journal of Dermatology

Volumn 24, Issue 3, 2014, Pages 330-334

  Dreno, Brigitte ^a   Thiboutot, Diane ^b   Gollnick, Harald ^c   Bettoli, Vincenzo ^d   Kang, Sewon ^e   Leyden, James J ^f   Shalita, Alan ^g   Torres, Vicente ^h  

^a UNIVERSITÉ DE NANTES   (France)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF FERRARA   (Italy)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g STATE UNIVERSITY OF NEW YORK   (United States)

^h Juarez Hospital   (Mexico)

Author keywords

Acne; Antibiotics; Antimicrobial resistance; Public health

Indexed keywords

ANTIINFECTIVE AGENT;

ACNE VULGARIS; DRUG UTILIZATION; HUMAN; STANDARDS; STATISTICS AND NUMERICAL DATA;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; HUMANS;

EID: 84905699352     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2014.2309     Document Type: Article

References (44)

1. G8 ministers pledge to act on bacterial antibiotic resistance. Financial Times 2013; June 13.
2. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49(1 Suppl): S1-37.
3. Narahari S, Gustafson CJ, Feldman SR. What's new in antibiotics in the management of acne? G Ital Dermatol Venereol 2012; 147: 227-38.
4. Kinney MA, Yentzer BA, Fleischer AB Jr., Feldman SR. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? J Drugs Dermatol 2010; 9: 519-24.
5. Forum WE. Global Risks 20132013: Available from: http://reports.weforum.org/global-risks-2013/view/risk-case-1/thedangers- of-hubris-on-human-health/#read.
6. Pulcini C, Gyssens IC. How to educate prescribers in antimicrobial stewardship practices. Virulence 2013; 4: 192-202.
7. Dreno B, Bettoli V, Ochsendorf F, et al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004; 14: 391-9.
8. Cooper AJ. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust 1998; 169: 259-61.
9. Mills O Jr., Thornsberry C, Cardin CW, Smiles KA, Leyden JJ. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Dermato-Venereol 2002; 82: 260-5.
10. Luk NM, Hui M, Lee HC, et al. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. J Eur Acad Dermatol Venereol 2013; 27: 31-6.
11. Abdel Fattah NS, Darwish YW. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study. J Eur Acad Dermatol Venereol 2012 Dec 20 [epub ahead of print].
12. Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol 2011; 4: 40-7.
13. Schafer F, Fich F, Lam M, Garate C, Wozniak A, Garcia P. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. Int J Dermatol 2013; 52: 418-25.
14. Tzellos T, Zampeli V, Makrantonaki E, Zouboulis CC. Treating acne with antibiotic-resistant bacterial colonization. Expert Opin Pharmacother 2011; 12: 1233-47.
15. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41-5.
16. Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004; 364: 2188-95.
17. Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 2003; 139: 467-71.
18. Nord CE, Oprica C. Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects. Anaerobe 2006; 12: 207-10.
19. Ross JI, Eady EA, Carnegie E, Cove JH. Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. J Antimicrob Chemother 2002; 49: 165-8.
20. Ross JI, Eady EA, Cove JH, Cunliffe WJ. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother 1998; 42: 1702-5.
21. Rosen T. Antibiotic resistance: an editorial review with recommendations. J Drugs Dermatol 2011; 10: 724-33.
22. Mendoza N, Hernandez PO, Tyring SK, Haitz KA, Motta A. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia. Int J Dermatol 2013; 52: 688-92.
23. Moon SH, Roh HS, Kim YH, Kim JE, Ko JY, Ro YS. Antibiotic resistance of microbial strains isolated from Korean acne patients. J Dermatol 2012; 39: 833-7.
24. Dumont-Wallon G, Moyse D, Blouin E, Dreno B. Bacterial resistance in French acne patients. Int J Dermatol 2010; 49: 283-8.
25. Gonzalez R, Welsh O, Ocampo J, et al. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico. Int J Dermatol 2010; 49: 1003-7.
26. Leyden JJ. The evolving role of Propionibacterium acnes in acne. Semin Cutan Med Surg 2001; 20: 139-43.
27. Leyden JJ, McGinley KJ, Mills OH, Kligman AM. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975; 65: 382-4.
28. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60(5 Suppl): S1-50.
29. Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol 2013 Oct 18. Epub ahead of print.
30. Skidmore R, Kovach R, Walker C, et al. Effects of subantimicrobialdose doxycycline in the treatment of moderate acne. Arch Dermatol 2003; 139: 459-64.
31. Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. J Drugs Dermatol 2008; 7: 1149-52.
32. Plewig GK, Kligman A. Acne and Rosacea, 3rd ed. New York: Springer, 2000.
33. Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. J Am Acad Dermatol 2010; 63: 52-62.
34. Zampeli VA, Makrantonaki E, Tzellos T, Zouboulis CC. New pharmaceutical concepts for sebaceous gland diseases: implementing today's pre-clinical data into tomorrow's daily clinical practice. Curr Pharm Biotech 2012; 13: 1898-913.
35. Abdel-Naser MB, Zouboulis CC. Clindamycin phosphate/ tretinoin gel formulation in the treatment of acne vulgaris. Exp Opin Pharmacother 2008; 9: 2931-7.
36. Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology 2001; 203: 277-9.
37. Yoon JY, Kwon HH, Min SU, Thiboutot DM, Suh DH. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes. J Invest Dermatol 2013; 133: 429-40.
38. Del Rosso JQ, Kim GK. Topical antibiotics: therapeutic value or ecologic mischief? Dermatol Ther 2009; 22: 398-406.
39. Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. Br J Dermatol 2005; 153: 395-403.
40. Kircik L. Rapid and efficacious fixed-combination monotherapy: desired results for the patient and improved adherence for the clinician. Cutis 2009; 84(5 Suppl): 5-11.
41. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997; 37: 590-5.
42. Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012; 26 Suppl 1: 1-29.
43. Campo M, Zuluaga A, Escobar P, et al. A comparative study on the effectiveness of lymecicline and adapalene versus minocicline and adapalene in the treatment of acne vulgaris. 20th World Congress of Dermatology. Paris, France 2002 P0005.
44. Monk E, Shalita A, Siegel DM. Clinical applications of nonantimicrobial tetracyclines in dermatology. Pharmacol Res 2011; 63: 130-45.